Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users
- 1 June 2004
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (9) , 1321-1325
- https://doi.org/10.1097/00002030-200406180-00011
Abstract
To investigate the impact of non-lipodystrophy HAART-related side effects on unprotected sexual behaviours among HIV-infected drug users. DESIGNAND PARTICIPANTS: HAART-treated patients who reported having occasional partners during the follow-up period after HAART initiation were selected among patients of the MANIF 2000 cohort of HIV-infected drug users. Visits where patients reported unsafe sexual behaviours with occasional partners were compared to visits where they reported safe sexual behaviours using a logistic model based on Generalized Estimating Equations. One-hundred and ninety-two HAART-treated patients reported occasional sexual partners at least once during follow-up, accounting for a total of 464 visits. Among these 192 patients, 134 (70%) declared at least once unsafe sexual behaviours with occasional partners. During follow-up, three or more HAART-related side effects were reported in 273 of the 464 visits. When comparing visits where patients reported unsafe sexual behaviours with occasional partners (n = 249) with those where they reported safe sexual behaviours (n = 215), experiencing three or more HAART-related side effects was significantly associated with unsafe sex after adjustment for cofactors such as injecting drug status, reporting more than two sexual partners and having sex more than once a week. Perceived side effects play a role in determining unsafe sexual behaviours. HIV prevention interventions must consider the negative impact of HAART-related side effects on sexual risk-taking behaviours. Drug maintenance programs contribute to sexual risk reduction among drug injecting patients.Keywords
This publication has 28 references indexed in Scilit:
- Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug usersAIDS, 2003
- Increases in Gonorrhea and Sexual Risk Behaviors Among Men Who Have Sex With Men:Sexually Transmitted Diseases, 2003
- Impact of Lipodystrophy on the Quality of Life of HIV-1–Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism?AIDS, 2002
- Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug usersJournal of Epidemiology and Community Health, 2002
- Protease Inhibitor Combination Therapy and Decreased Condom Use Among Gay MenSouthern Medical Journal, 2002
- Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual menAIDS, 2002
- Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug usersAIDS, 2001
- Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDSThe Lancet, 2001
- New therapy explains the fall in AIDS incidence with a substantial rise in number of persons on treatment expectedAIDS, 1999